We are live on ! Find out more
VP

Vitruvian Partners Portfolio holdings

AUM $112M
1-Year Est. Return 2.02%
This Fund
S&P 500
This Quarter Est. Return
+27.45%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
–
AUM
$164M
AUM Growth
+$59.4M
Cap. Flow
+$30.2M
Cap. Flow %
18.36%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
HNGE
Hinge Health
HNGE
+$50.5M

Top Sells

Rank Stock Value
1
MQ icon
Marqeta
MQ
+$18.6M
2
XMTR icon
Xometry
XMTR
+$1.81M

Sector Composition

Rank Sector Weight
1 Healthcare 47.91%
2 Technology 24.33%
3 Consumer Discretionary 22.14%
4 Industrials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HNGE
1
Hinge Health
HNGE
$6.79B
$64.7M 39.39%
+1,250,000
New +$50.5M
MQ icon
2
Marqeta
MQ
$1.85B
$40M 24.33%
1,713,296
-978,250
-36% -$18.6M
CARG icon
3
CarGurus
CARG
$3.17B
$31.7M 19.28%
945,919
– –
MXCT icon
4
MaxCyte
MXCT
$125M
$11M 6.7%
5,043,356
– –
XMTR icon
5
Xometry
XMTR
$5.53B
$9.23M 5.62%
273,060
-61,725
-18% -$1.81M
GLBE icon
6
Global E Online
GLBE
$6.14B
$4.7M 2.86%
140,037
– –
RXST icon
7
RxSight
RXST
$232M
$3M 1.83%
230,743
– –

Similar funds

RTM
Red Tree Management Redwood City, California $112M AUM 91.52% 1-Year Est. Return
JE
Jacobs Equity Draper, Utah $112M AUM
GW
Graetz Wealth Jenison, Michigan $112M AUM
SPWM
Smith Partners Wealth Management Greensboro, North Carolina $112M AUM
OCA
Odyssey Capital Advisors Bala Cynwyd, Pennsylvania $112M AUM
APFP
Action Point Financial Planning Grand Rapids, Michigan $112M AUM
FCU
Financial Concepts Unlimited Centreville, Maine $112M AUM
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Vitruvian Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Vitruvian Partners held 7 positions worth $164M, up 57% from $105M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Vitruvian Partners deployed $30.2M of net new capital in Q2 2025, opening 1 new position. Its largest new stake was Hinge Health: 1,250,000 shares worth $64.7M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Marqeta, an estimated $18.6M trimmed.

  • Vitruvian Partners's largest Q2 2025 buy was Hinge Health: 1,250,000 shares worth $64.7M.
  • Vitruvian Partners's biggest Q2 2025 reduction was Marqeta, cutting an estimated $18.6M.
  • Vitruvian Partners's ten largest holdings make up 100% of its $164M portfolio in Q2 2025.
  • Vitruvian Partners opened 1 new position and closed 0 in Q2 2025.
  • Vitruvian Partners's portfolio value rose 57% quarter-over-quarter to $164M.

Based on Vitruvian Partners's 13F filing for Q2 2025, filed 11 Aug 2025.